Evidence map›Paper›PMID 26490367›Full record

ArticleImplementation science : IS2015

Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials.

Vivian Welch, J Jull, J Petkovic, R Armstrong, Y Boyer, L G Cuervo, Sjl Edwards, A Lydiatt, D Gough, J Grimshaw and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Implementation science : IS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Considerations and guidance in designing equity-relevant clinical trials.International journal for equity in health · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Vivian WelchBruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose, Ottawa, Ontario, Canada. vivian.welch@uottawa.ca.
J JullBruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose, Ottawa, Ontario, Canada. jjull013@uottawa.ca.
J PetkovicBruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose, Ottawa, Ontario, Canada. jennnifer.petkovic@uottawa.ca.
R ArmstrongCentre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, 5/207 Bouverie St Carlton 3010, Victoria, Australia. armr@unimelb.edu.au.
Y BoyerCanada Research Chair in Aboriginal Health and Wellness, Brandon University, Manitoba, Canada. yboyer@gmail.com.
L G CuervoResearch Promotion and Development Office of Knowledge Management, Bioethics and Research Pan American Health Organization, World Health Organization, Washington, DC, USA. CuervoLu@PAHO.org.
Sjl EdwardsResearch Ethics and Governance, University College London, London, England. sarah.edwards@ucl.ac.uk.
A LydiattCochrane Musculoskeletal Group, London, Ontario, Canada. alydiatt@primus.ca.
D GoughDepartment of Social Science, University College London, London, UK. D.Gough@ioe.ac.uk.
J GrimshawOttawa Hospital Research Institute, Medicine University of Ottawa, Ottawa, Canada. jgrimshaw@ohri.ca.
E KristjanssonSchool of Psychology, Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada. kristjan@uottawa.ca.
L MbuagbawDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. mbuagblc@mcmaster.ca.
J McGowanDepartment of Medicine, University of Ottawa, Ontario, Canada. jmcgowan@uottawa.ca.
D MoherOttawa Hospital Research Institute; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada. dmoher@ohri.ca.
T PantojaDepartment of Family Medicine, Pontificia Universidad Católica de Chile, Centro Médico San Joaquín Vicuña Mackenna 4686, Macul, Santiago, Chile. tpantoja@med.puc.cl.
M PetticrewDepartment of Social and Environmental Health Research, Public Health Evaluation, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, England. Mark.Petticrew@lshtm.ac.uk.
K PottieDepartments of Family Medicine and Epidemiology and Community Medicine Primary Care Research Group and Equity Methods Group, Bruyere Research Institute; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada. kpottie@uottawa.ca.
T RaderCanadian Agency for Drugs and Technology in Health, 865 Carling Ave Ottawa, Ontario, Canada. tamarar@cadth.ca.
B SheaBruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose, Ottawa, Ontario, Canada. bevshea35@gmail.com.
M TaljaardClinical Epidemiology Program, Ottawa Hospital Research Institute; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ontario, Canada. mtaljaard@ohri.ca.
E WatersPublic Health Insight, Melbourne School of Population and Global Health, University of Melbourne, 5/207 Bouverie St Carlton 3010, Victoria, Australia. ewaters@unimelb.edu.au.
C WeijerRotman Institute of Philosophy, Western University, 1151 Richmond Street, London, Ontario, Canada. cweijer@uwo.ca.
G A WellsDepartment of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. gawells@ottawaheart.ca.
H WhiteAlfred Deakin University, Geelong, Victoria, Australia. howardwhite@c2admin.org.
M WhiteheadDepartment of Public Health and Policy, University of Liverpool, Liverpool, UK. mmw@liverpool.ac.uk.
P TugwellBruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose, Ottawa, Ontario, Canada. ptugwell@uottawa.ca.

Funding

CIHRWorld Health Organization 001
6 · The paper itself

Abstract

backgroundHealth equity concerns the absence of avoidable and unfair differences in health. Randomized controlled trials (RCTs) can provide evidence about the impact of an intervention on health equity for specific disadvantaged populations or in general populations; this is important for equity-focused decision-making. Previous work has identified a lack of adequate reporting guidelines for assessing health equity in RCTs. The objective of this study is to develop guidelines to improve the reporting of health equity considerations in RCTs, as an extension of the Consolidated Standards of Reporting Trials (CONSORT). METHODS/

designA six-phase study using integrated knowledge translation governed by a study executive and advisory board will assemble empirical evidence to inform the CONSORT-equity extension. To create the guideline, the following steps are proposed: (1) develop a conceptual framework for identifying "equity-relevant trials," (2) assess empirical evidence regarding reporting of equity-relevant trials, (3) consult with global methods and content experts on how to improve reporting of health equity in RCTs, (4) collect broad feedback and prioritize items needed to improve reporting of health equity in RCTs, (5) establish consensus on the CONSORT-equity extension: the guideline for equity-relevant trials, and (6) broadly disseminate and implement the CONSORT-equity extension. DISCUSSION: This work will be relevant to a broad range of RCTs addressing questions of effectiveness for strategies to improve practice and policy in the areas of social determinants of health, clinical care, health systems, public health, and international development, where health and/or access to health care is a primary outcome. The outcomes include a reporting guideline (CONSORT-equity extension) for equity-relevant RCTs and a knowledge translation strategy to broadly encourage its uptake and use by journal editors, authors, and funding agencies.

Indexed as

Guidelines as TopicResearch DesignAge FactorsCultureHealth EquityHumansRandomized Controlled Trials as TopicSex FactorsSocioeconomic Factors

Identifiers

PMID26490367
PMCPMC4618136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.